FDA Approved: GONAL-F RFF REDI-JECT — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for GONAL-F RFF REDI-JECT (follitropin) submitted by EMD Serono, updating the product labeling for the REDI-JECT aut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anovulatory Infertility
• Infertility

Drugs mentioned

• GONAL-F RFF REDI-JECT (Follitropin)

Snippet

SUPPL AP for GONAL-F RFF REDI-JECT (FOLLITROPIN)